Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.

• Takumi Kawaguchi, Eitaro Taniguchi, +4 authors Michio Sata
• Liver international : official journal of the…
• 2010

BACKGROUND Diabetes mellitus is frequently seen in hepatitis C patients and is often treated with antidiabetic agents that increase serum insulin levels. Because insulin is a growth-promoting… (More)

CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation.

• Tatsuyuki Tonan, K. Fujimoto, +7 authors Takato Ueno
• Journal of gastroenterology and hepatology
• 2012

BACKGROUND AND AIM Kupffer cell (KC) function and CD14 expression contributes to pathogenesis of non-alcoholic steatohepatitis (NASH). However, these relationships remain unclear. We investigated the… (More)

Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan.

• Yasuyo Morita, Takato Ueno, +6 authors Michio Sata
• Alcoholism, clinical and experimental research
• 2005

BACKGROUND This study compared the liver histology of patients with NASH and patients with ASH. METHODS Subjects consisted of 79 patients (41 in the NASH group and 38 in the ASH group). We… (More)

Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes.

• Yasuyo Morita, Takato Ueno, +4 authors Michio Sata
• Hepato-gastroenterology
• 2005

BACKGROUND/AIMS In the present study we administered nateglinide to nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes who had failed to respond adequately to diet and exercise… (More)

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

• Ryukichi Kumashiro, Tatsuya Ide, +10 authors Michio Sata
• Hepatology research : the official journal of the…
• 2002

T-cell hyporesponsiveness may lead to chronicity of hepatitis C virus (HCV) infection. We evaluated whether interferon (IFN)-gamma injection can bring a Th1-dominant environment to patients with… (More)

Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).

• Nozomi Sasaki, Takato Ueno, Yasuyo Morita, Eisuke Nagata, Michio Sata
• Hepato-gastroenterology
• 2006

BACKGROUND/AIMS In the present study, we examined the usefulness of serum hepatic fibrosis markers for the diagnosis of nonalcoholic steatohepatitis (NASH). METHODOLOGY The subjects were 16… (More)

Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan.

• Tatsuya Ide, Michio Sata, +9 authors Hirohito Tsubouchi
• Hepatology research : the official journal of the…
• 2010

BACKGROUND AND AIM There has so far been no questionnaire report on patients who were treated with peginterferon plus ribavirin (PEG IFN+RBV) therapy. The purpose of this study was to investigate the… (More)

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

• Teruko Hino, Ryukichi Kumashiro, +10 authors Michio Sata
• International journal of molecular medicine
• 2003

The prognosis of patients with autoimmune hepatitis (AIH) has not been clearly defined. The aim of this study was to define the prognostic factors of AIH in a population with long-term follow-up in… (More)

[Obesity and liver diseases].

• Michio Sata, Takato Ueno, Yasuyo Morita
• Nihon Naika Gakkai zasshi. The Journal of the…
• 2006

The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.

• Koichiro Kuhara, Tatsuya Ide, +13 authors Michio Sata
• The Kurume medical journal
• 2012

UNLABELLED Some patients receiving pegylated interferon and ribavirin treatment for chronic hepatitis C are forced to discontinue the treatment due to psychiatric disorders. We performed a… (More)

• ‹
• 1
• 2
• ›